<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04705948</url>
  </required_header>
  <id_info>
    <org_study_id>UTEM POST</org_study_id>
    <nct_id>NCT04705948</nct_id>
  </id_info>
  <brief_title>Comparing the Effect of Ketamine and Magnesium Sulfate Gargling With Placebo on Post-operative Sore Throat</brief_title>
  <official_title>Comparing the Effect of Ketamine and Magnesium Sulfate Gargling With Placebo on Post-operative Sore Throat: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Tunis El Manar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Tunis El Manar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective randomized double-blind study including patients ASA I-II, aged more than 18&#xD;
      years undergoing surgery under general anesthesia (GA) and endotracheal intubation. Patients&#xD;
      were randomized allocated into 2 groups: ketamine group received ketamine gargle (0.5 mg/kg&#xD;
      up to 30 ml dextrose water) and magnesium group received magnesium sulfate gargle (20 mg/kg&#xD;
      up to 30 mL dextrose water ) 15 minutes before the operation.&#xD;
&#xD;
      Our primary outcome is sore throat and the secondary judging criteria are cough, dysphonia&#xD;
      and satisfaction. A standardized anesthesia protocol was followed for all patients. After&#xD;
      extubation, the patients were asked to grade POST, hoarseness, and cough at 15 min, 1h, and&#xD;
      24 h.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, single-center, randomized, double-blind study. the investigators&#xD;
      included in the study the patients:&#xD;
&#xD;
      whose age is greater than or equal to 18 years; ASA class 1 or 2, proposed for elective&#xD;
      visceral, orthopedic, oncology, ophthalmologic, urologic surgery under general anesthesia&#xD;
      with orothracheal intubation, expected duration ≤ 120 min.&#xD;
&#xD;
      the non-inclusion criteria are known allergy to ketamine or maguisuim sulphate, ASA 3 and&#xD;
      more, cervical surgery; rapid sequence induction, difficult intubation planned or history of&#xD;
      difficult intubation, malformation of the O.R.L sphere; upper respiratory tract infections.&#xD;
      the need for multiple laryngoscopies for orotracheal intubation (≥ 2 attempts); the need for&#xD;
      a postoperative nasogastric tube.&#xD;
&#xD;
      randomization is performed upon entering the operating room. The gargle allocation scheme,&#xD;
      Ketamine Group or Magnesium Sulfate Group was randomly generated using a randomization table&#xD;
      with an allocation ratio of 1: 1.&#xD;
&#xD;
      Postoperative follow-up was carried out in the post-intervention monitoring room then in&#xD;
      hospitalization within the various referring services (general surgery, orthopedics, O.R.L&#xD;
      and ophthalmology).&#xD;
&#xD;
      On the day of the procedure, the doctor responsible for the study prepares the two types of&#xD;
      solutions containing:&#xD;
&#xD;
        -  One of magnesium sulfate (20mg / kg diluted in 30cc of 5% glucose serum);&#xD;
&#xD;
        -  The other ketamine (50mg diluted in 30cc of 5% glucose serum). These two solutions were&#xD;
           distributed over two groups of patients for use as a gargle, lasting at least 60 seconds&#xD;
           for each patient in each group and 15 minutes before the surgery.&#xD;
&#xD;
      The primary endpoint is the incidence and severity of POST at the twenty-fourth hour&#xD;
      postoperatively The secondary outcomes are the incidence and severity of POST at 15 minutes&#xD;
      and one hour postoperatively; The occurrence of cough, The presence of dysphonia and Patient&#xD;
      satisfaction&#xD;
&#xD;
      The severity of POST was scored on a three-point score from 0 to 2 (0 = No pain; 1 =&#xD;
      Oropharyngeal pain on speaking; 2 = Spontaneous oropharyngeal pain)&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 7, 2020</start_date>
  <completion_date type="Actual">February 7, 2021</completion_date>
  <primary_completion_date type="Actual">February 7, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>severity of post-operative sore throat</measure>
    <time_frame>at the twenty-fourth hour postoperatively</time_frame>
    <description>The severity of POST was scored on a three-point score from 0 to 2 (0 = No pain; 1 = Oropharyngeal pain on speaking; 2 = Spontaneous oropharyngeal pain)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>at the twenty-fourth hour postoperatively</time_frame>
    <description>score of three points: satisfied (2 points); moderately satisfied (1 points); not satisfied (0 points)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>the incidence of cough</measure>
    <time_frame>at the twenty-fourth hour postoperatively</time_frame>
    <description>no cough 0 point and presence 1 point</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>ketamine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>ketamine gargle (0.5 mg/kg up to 30 ml dextrose water) 15 minutes before the operation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>magnesium sulfate group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>magnesium sulfate gargle (20 mg/kg up to 30 mL G5%) 15 minutes before the operation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Magnesium sulfate versus ketamine</intervention_name>
    <description>Magnesium sulfate versus ketamine for of post-operative sore throat after endotracheal intubation</description>
    <arm_group_label>ketamine group</arm_group_label>
    <arm_group_label>magnesium sulfate group</arm_group_label>
    <other_name>postoperative complication</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age is greater than or equal to 18 years&#xD;
&#xD;
          -  ASA class 1 or 2&#xD;
&#xD;
          -  patients proposed for elective visceral, orthopedic, oncology, ophthalmologic,&#xD;
             urologic surgery under general anesthesia with orothracheal intubation&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  known allergy to ketamine or maguisuim sulphate&#xD;
&#xD;
          -  ASA 3 and more&#xD;
&#xD;
          -  cervical surgery&#xD;
&#xD;
          -  difficult intubation planned or history of difficult intubation&#xD;
&#xD;
          -  malformation of the O.R.L sphere&#xD;
&#xD;
          -  the need for multiple laryngoscopies for orotracheal intubation (≥ 2 attempts);&#xD;
&#xD;
          -  the need for a postoperative nasogastric tube.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>mechaal benali, PROFESSOR</last_name>
    <role>Study Director</role>
    <affiliation>university manar Tunis tunisia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mechaal Benali</name>
      <address>
        <city>Nabeul</city>
        <state>Mrezga Hammamet</state>
        <zip>8000</zip>
        <country>Tunisia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Tunisia</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>January 8, 2021</study_first_submitted>
  <study_first_submitted_qc>January 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 12, 2021</study_first_posted>
  <last_update_submitted>May 9, 2021</last_update_submitted>
  <last_update_submitted_qc>May 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Tunis El Manar</investigator_affiliation>
    <investigator_full_name>Mechaal Benali</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>sore throat</keyword>
  <keyword>Ketamine</keyword>
  <keyword>magnesium sulfate</keyword>
  <keyword>endotracheal intubation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharyngitis</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Magnesium Sulfate</mesh_term>
    <mesh_term>Ketamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

